:

SATISPAY EYES €120M FUNDING FOR EXPANSION

INDUSTRY DESK1 MIN READ
THU, JUN 11, 2026

■ AI-SUMMARIZED FROM 2 SOURCES ▸ TIMELINE

Italian fintech unicorn Satispay is planning a funding round of up to €120 million ($139 million) to accelerate expansion into new financial products and fund potential acquisitions.

The Milan-based payments company aims to use the capital to broaden its product offerings beyond its core payment solution. The funding will also provide strategic flexibility for M&A activity as Satispay positions itself for growth in the competitive European fintech landscape. Satispay has built its business around a mobile-first payments platform that enables consumers and merchants to conduct transactions directly. The company achieved unicorn status—a valuation exceeding $1 billion—following strong market adoption across Italy and expansion into other European markets. The funding round comes as fintech companies increasingly seek capital to diversify revenue streams and consolidate market share. Satispay's push into adjacent financial products suggests the company is moving beyond payments into a broader financial services offering. Details on valuation, timeline, and investor participation have not been disclosed. The company has not yet confirmed the funding round's completion.

■ SOURCES

Bloomberg TechBloomberg Tech

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

DeepSeek's annualized revenue run rate has doubled to $1 billion in recent months, up from less than $500 million. The Chinese AI company aims to close a $7.5 billion fundraise by late October.

1H AGOAI Desk

Modal Labs and Baseten, two platforms enabling businesses to run AI models, are in advanced funding talks that would significantly boost their valuations. The rounds reflect growing investor appetite for AI infrastructure services.

12H AGOAI Desk

Ema, an AI agent platform automating corporate processes in HR, IT, and finance, secured $77 million in Series B funding led by Creaegis. The round brings the startup's total funding to $140 million.

14H AGOAI Desk

Enveda Therapeutics raised $311 million in funding, bringing the AI biotech company's valuation to $2 billion. The capital will accelerate clinical trials for drugs derived from natural compounds.

15H AGOAI Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.